s 135 has been researched along with beta-carboline-3-carboxylic acid methyl ester in 2 studies
Studies (s 135) | Trials (s 135) | Recent Studies (post-2010) (s 135) | Studies (beta-carboline-3-carboxylic acid methyl ester) | Trials (beta-carboline-3-carboxylic acid methyl ester) | Recent Studies (post-2010) (beta-carboline-3-carboxylic acid methyl ester) |
---|---|---|---|---|---|
8 | 0 | 0 | 145 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eigyo, M; Kawasaki, K; Matsushita, A; Murata, S; Sasatani, T; Shindo, H; Takada, S | 1 |
Fan, B; Ma, W; Xia, B; Zhang, X; Zheng, B | 1 |
2 other study(ies) available for s 135 and beta-carboline-3-carboxylic acid methyl ester
Article | Year |
---|---|
A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
Topics: Administration, Oral; Animals; Anticonvulsants; Indicators and Reagents; Male; Mice; Pentylenetetrazole; Pyrazoles; Quinolines; Receptors, GABA-A; Seizures; Thiophenes | 1987 |
Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
Topics: Ligands; Quantitative Structure-Activity Relationship; Receptors, GABA-A | 2008 |